1 / 4

Benign Prostatic Hyperplasia Treatment Market: Analysis Report, Share, Trends and Overview 2019-2025

The global benign prostatic hyperplasia treatment market is estimated to witness significant growth during the forecast period. The rising demand for innovative treatment options for benign prostatic hyperplasia is driving the market growth. 5 alpha-reductase inhibitors are the new innovation in benign prostatic hyperplasia drug treatment market.

globalomr
Download Presentation

Benign Prostatic Hyperplasia Treatment Market: Analysis Report, Share, Trends and Overview 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Benign Prostatic Hyperplasia Treatment Market to 2025, Future Outlook, COVID-19 Impact Analysis, Forecast 2019-2025 Request a sample of our report on Benign Prostatic Hyperplasia Treatment Market: https://www.omrglobal.com/request-sample/benign-prostatic-hyperplasia-treatment-market

  2. The global benign prostatic hyperplasia treatment market is estimated to witness significant growth during the forecast period. The rising demand for innovative treatment options for benign prostatic hyperplasia is driving the market growth. 5 alpha-reductase inhibitors are the new innovation in benign prostatic hyperplasia drug treatment market. This helps to treat the lower urinary tract. Further, artery embolization is the new innovation in minimally invasive procedure alternatives to surgery for benign prostatic hyperplasia treatment. This procedure is less costly and less painful, with no hospital stay. Transurethral resection of the prostate (TURP) is one of the innovation in the minimally invasive procedure; this was developed by the surgical urology team at Penn State Health Milton S. Hershey Medical Center. Rezum, a minimally invasive technology one of the innovations in this field for the treatment of benign prostatic hyperplasia. Rezum is used for prostate volumes greater than 30 cm3. (Get 15% Discount on Buying this Report) A https://www.omrglobal.com/industry-reports/benign-prostatic-hyperplasia-treatment-market full report of Benign Prostatic Hyperplasia Treatment Market is available at: Due to the very low-risk rate, prostatic hyperplasia patients are moving towards laser therapy/surgeries. For patients with moderate or large prostates often prefer laser surgery. Some of the innovations in the laser surgeries are holmium and Photoselective Vaporization of the Prostate (PVP), Holmium Laser Enucleation of the Prostate (HoLEP), and others. Photoselective Vaporization of the Prostate (PVP) is also known as “Greenlight laser”. This is a minimally invasive technique, it uses high-powered laser light to vaporize the overgrowth of prostate cells. Holmium Laser Enucleation of the Prostate (HoLEP), this laser surgery used to remove the blockages of urine flow, this procedure is done without any cut in the body. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/benign-prostatic-hyperplasia-treatment-market Global Benign Prostatic Hyperplasia Treatment Market Segmentation Types of Treatment Medications oAlpha-blockers o5 Alpha reductase inhibitor (ARIs) oPhosphodiesterase-5 Enzyme Inhibitor oOthers Minimally Invasive Procedures oTransurethral Resection of the Prostate (TURP) oTransurethral Incision of the Prostate (TUIP) oTransurethral Microwave Thermotherapy (TUMT) oTransurethral Needle Ablation (TUNA)

  3. Laser Therapy oAblative procedures oEnucleation procedures Others For more customized data, request for report customization @ https://www.omrglobal.com/report- customization/benign-prostatic-hyperplasia-treatment-market Global Benign Prostatic Hyperplasia Treatment Market – Segment by Region North America US Canada Europe Germany UK France Spain Italy Rest of Europe Asia-Pacific China Japan India Rest of Asia-Pacific Rest of the World Company Profiles Abbott Laboratories Allergan, Inc. Astellas Pharma, Inc. Boehringer Ingelheim GmbH Boston Scientific Corp. Camber Pharmaceuticals, Inc. Coloplast A/S

  4. Daiichi Sankyo Co., Ltd. Eli Lilly &Co. Endo International PLC GlaxoSmithKline PLC Karl Storz GmbH& Co.Kg Lumenis, Ltd. Merck & Co., Inc. Nymox Pharmaceutical Corp. Olympus Corp. Pfizer, Inc. ProArc Medical, Ltd. Sanofi S.A. Reasons to Buying From us – 1.We cover more than 15 major industries, further segmented into more than 90 sectors. 2.More than 120 countries are for analysis. 3.Over 100+ paid data sources mined for investigation. 4.Our expert research analysts answer all your questions before and after purchasing your report. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 7803-040-404

More Related